Ablation generator

Skip to: Description  ·  Claims  ·  References Cited  · Patent History  ·  Patent History
Description

The file of this patent contains at least one drawing/photograph executed in color. Copies of this patent with color drawing(s)/photograph(s) will be provided by the Office upon request and payment of the necessary fee.

FIG. 1 is a perspective view of a first embodiment of an ablation generator of our new design.

FIG. 2 is a front elevation thereof.

FIG. 3 is a rear elevation thereof.

FIG. 4 is a right side elevation thereof.

FIG. 5 is a left side elevation thereof.

FIG. 6 is a top plan view thereof.

FIG. 7 is a bottom plan view thereof.

FIG. 8 is an enlarged view of the area identified by numeral “8” in FIG. 1, illustrating the horizontal line features as surface ornamentation.

FIG. 9 is a perspective view of a second embodiment of an ablation generator of our new design.

FIG. 10 is a front elevation thereof.

FIG. 11 is a rear elevation thereof.

FIG. 12 is a right side elevation thereof.

FIG. 13 is a left side elevation thereof.

FIG. 14 is a top plan view thereof; and,

FIG. 15 is a bottom plan view thereof.

The horizontal line features depicted on the left and right sides of the front surface of the ablation generator in the second embodiment are surface ornamentation having an appearance similar to the horizontal line features illustrated in FIG. 8.

In the drawings, the broken lines are for the purpose of illustrating portions of the ablation generator that forms no part of the claimed design.

Claims

The ornamental design for an ablation generator, as shown and described.

Referenced Cited
U.S. Patent Documents
3650277 March 1972 Sjostrand et al.
4658819 April 21, 1987 Harris et al.
5035694 July 30, 1991 Kasprzyk et al.
5255679 October 26, 1993 Imran
5300068 April 5, 1994 Rosar et al.
D351655 October 18, 1994 Smith
5368591 November 29, 1994 Lennox et al.
5387233 February 7, 1995 Alferness et al.
D359353 June 13, 1995 Butter
5465717 November 14, 1995 Imran et al.
5531779 July 2, 1996 Dahl et al.
5598848 February 4, 1997 Swanson et al.
5607462 March 4, 1997 Imran
5628313 May 13, 1997 Webster, Jr.
5676662 October 14, 1997 Fleischhacker et al.
5707400 January 13, 1998 Terry, Jr. et al.
5769077 June 23, 1998 Lindegren
5772590 June 30, 1998 Webster, Jr.
5893885 April 13, 1999 Webster, Jr.
5897553 April 27, 1999 Mulier et al.
D411622 June 29, 1999 Hall
5954649 September 21, 1999 Chia
5954719 September 21, 1999 Chen
6004269 December 21, 1999 Crowley
6012457 January 11, 2000 Lesh
6016437 January 18, 2000 Tu
6024740 February 15, 2000 Lesh
6073048 June 6, 2000 Kieval
6096037 August 1, 2000 Mulier et al.
6117101 September 12, 2000 Diederich et al.
6161543 December 19, 2000 Cox et al.
6178349 January 23, 2001 Kieval
6200312 March 13, 2001 Zikorus et al.
6216044 April 10, 2001 Kordis
6233491 May 15, 2001 Kordis et al.
6283951 September 4, 2001 Flaherty et al.
6287608 September 11, 2001 Levin et al.
6292695 September 18, 2001 Webster, Jr. et al.
6322559 November 27, 2001 Daulton et al.
6460545 October 8, 2002 Kordis
6522926 February 18, 2003 Kieval et al.
D477408 July 15, 2003 Bromley
6613045 September 2, 2003 Laufer et al.
6616624 September 9, 2003 Kieval
6635054 October 21, 2003 Fjield et al.
6656174 December 2, 2003 Hedge et al.
6669655 December 30, 2003 Acker et al.
6699231 March 2, 2004 Sterman et al.
D491666 June 15, 2004 Kimmell
6748255 June 8, 2004 Fuimaono et al.
6805131 October 19, 2004 Kordis
6845267 January 18, 2005 Harrison et al.
6954977 October 18, 2005 Maguire et al.
6970730 November 29, 2005 Fuimaono et al.
7122031 October 17, 2006 Edwards et al.
7149574 December 12, 2006 Yun et al.
7155284 December 26, 2006 Whitehurst et al.
7162303 January 9, 2007 Levin et al.
7245955 July 17, 2007 Rashidi
D550357 September 4, 2007 Hayamizu
D552241 October 2, 2007 Bromley
7291146 November 6, 2007 Steinke et al.
D567761 April 29, 2008 Waaler
7363076 April 22, 2008 Yun et al.
D574323 August 5, 2008 Waaler
7419486 September 2, 2008 Kampa
7465288 December 16, 2008 Dudney et al.
7468062 December 23, 2008 Oral et al.
7481803 January 27, 2009 Kesten et al.
7653438 January 26, 2010 Deem et al.
7717948 May 18, 2010 Demarais et al.
7742795 June 22, 2010 Stone et al.
7850685 December 14, 2010 Kunis et al.
7949407 May 24, 2011 Kaplan et al.
8145316 March 27, 2012 Deem et al.
8224416 July 17, 2012 de la Rama et al.
8343213 January 1, 2013 Salahieh et al.
8347891 January 8, 2013 Demarais et al.
8442639 May 14, 2013 Walker et al.
8454594 June 4, 2013 Demarais et al.
D687146 July 30, 2013 Juzkiw
8545495 October 1, 2013 Scheib
D695407 December 10, 2013 Price
D704839 May 13, 2014 Juzkiw
D712352 September 2, 2014 George
D712353 September 2, 2014 George et al.
D712833 September 9, 2014 George
9022948 May 5, 2015 Wang
20020068885 June 6, 2002 Harhen et al.
20020120304 August 29, 2002 Mest
20030050681 March 13, 2003 Pianca
20030060858 March 27, 2003 Kieval et al.
20030074039 April 17, 2003 Puskas
20030114739 June 19, 2003 Fuimaono et al.
20030216792 November 20, 2003 Levin et al.
20030233099 December 18, 2003 Danaek et al.
20040215186 October 28, 2004 Cornelius et al.
20050288730 December 29, 2005 Deem et al.
20060089678 April 27, 2006 Shalev
20070135875 June 14, 2007 Demarais et al.
20080255478 October 16, 2008 Burdette
20090076409 March 19, 2009 Wu et al.
20100016762 January 21, 2010 Thapliyal et al.
20100094209 April 15, 2010 Drasler et al.
20100168737 July 1, 2010 Grunewald
20100249773 September 30, 2010 Clark et al.
20100268307 October 21, 2010 Demarais et al.
20100286684 November 11, 2010 Hata et al.
20110004087 January 6, 2011 Fish et al.
20110118726 May 19, 2011 de la Rama et al.
20110137298 June 9, 2011 Nguyen
20110160720 June 30, 2011 Johnson
20110213231 September 1, 2011 Hall et al.
20110257641 October 20, 2011 Hastings et al.
20110264011 October 27, 2011 Wu et al.
20110264086 October 27, 2011 Ingle
20120143097 June 7, 2012 Pike, Jr.
20120143298 June 7, 2012 Just et al.
20120296232 November 22, 2012 Ng
20120323233 December 20, 2012 Maguire et al.
20130116737 May 9, 2013 Edwards et al.
20130131743 May 23, 2013 Yamasaki et al.
20130144251 June 6, 2013 Sobotka
20130172715 July 4, 2013 Just et al.
20140330266 November 6, 2014 Thompson
Foreign Patent Documents
97/45157 December 1997 WO
00/66020 November 2000 WO
01/00273 January 2001 WO
01/22897 April 2001 WO
02/26314 April 2002 WO
03/082080 October 2003 WO
2006/041881 April 2006 WO
2007/149970 December 2007 WO
2008/141150 November 2008 WO
2008/151001 December 2008 WO
2012/064818 May 2012 WO
2012/106492 August 2012 WO
Other references
  • Dibona, Gerald F., Sympathetic Nervous System and Hypertension, Hypertension Journal of The American Heart Association, Jan. 28, 2013; 61: 556-560.
  • Doumas, Michael et al, Interventional Management of Resistant Hypertension, The Lancet, vol. 373, Apr. 11, 2009, pp. 1228-1230.
  • Elmula, Fadl et al, Renal Sympathetic Denervation in Patients With Treatment-Resistant Hypertension After Witnessed Intake of Medication Before Qualifying Ambulatory Blood Pressure, Hypertension Jul. 8, 2013;62:526-532.
  • Goldberg, Michael R et al, Reconstructive Vascular Surgery for Renovascular Hypertension, Can Med Assoc J_ Feb. 2, 1974;110(3):275-80.
  • Howard, James P. et al, Size of Blood Pressure Reduction from Renal Denervation: Insights from Meta-Analysis of Antihypertensive Drug Trials of 4121 Patients with Focus on Trial Design: the Converge Report, Heart, Sep. 15, 2013; 0:1-9.
  • Howard, James P. et al, Unintentional Overestimation of an Expected Antihypertensive Effect in Drug and Device Trials: Mechanisms and Solutions, International Journal of Cardiology, vol. 172, Issue 1, Mar. 1, 2014, pp. 29-35.
  • Hoye, Neil A. et al, Endovascular Renal Denervation: A Novel Sympatholytic with Relevance to Chronic Kidney Disease, Clinical Kidney Journal Advance Access, Nov. 8, 2013; O: 1-8.
  • International Search Report and Written Opinion for Application No. PCT/US2010/054637 dated Jan. 3, 2011.
  • International Search Report and Written Opinion for Application No. PCT/US2010/054684 dated Jan. 10, 2011.
  • Moak, Jeffrey P_ et al, Case Report: Pulmonary Vein Stenosis Following RF Ablation of Paroxysmal Atrial Fibrillation: Successful Treatment with Balloon Dilation, Journal of Interventional Cardiac Electrophysiology, Dec. 2000, 4:621-631.
  • Mogil, Robert A_ et al, Renal Innervation and Renin Activity in Salt Metabolism and Hypertension, American Journal of Physiology, vol. 216, No. 4, Apr. 1969, 693-697.
  • Morita, Hironobu et al, Neural Control of Urinary Sodium Excretion During Hypertonic NaC1 Load in Conscious Rabbits: Role of Renal and Hepatic Nerves and Baroreceptors, Journal of the Autonomic Nervous System, 34 (1991) 157-170.
  • Morrissey, D.M. et al, Sympathectomy in the Treatment of Hypertension, The Lancet, Feb. 1953, 403-408.
  • Mort Ara, Andrea et al, Nonselective Beta-Adrenergic Blocking Agent, Carvedilol, Improves Arterial Baroflex Gain and Heart Rate Variability in Patients With Stable Chronic Heart Failure, Journal of the American College of Cardiology, vol. 36, No. 5, 2000, 1612-1618.
  • Moss, Jonathan, Interventional Radiology and Renal Denervation, Interventions, vol. 13, Issue 3, 2013; Nov. 28, 2013.
  • Naghavi, Morteza et al, Thermography Basket Catheter: In Vivo Measurement of the Temperature of Aherosclerotic Plaques for Detection of Vulnerable Plaques, Catheterization and Cardiovascular Interventions 59:52-59 (2003).
  • Naidoo, N. et al, Thoracic Splanchnic Nerves: Implications for Splanchnic Denervation, Journal of Anatomy, Nov. 2001;199(Pt 5):585-590.
  • Nakagawa, A. et al, Selective Ablation of Porcine and Rabbit Liver Tissue Using Radiofrequency: Preclinical Study, European Surgical Research, 1999;31:371-379.
  • Nakagawa, Hiroshi et al, Inverse Relationship Between Electrode Size and Lesion Size During Radiofrequency Ablation With Active Electrode Cooling, Circulation. Aug. 4, 1998;98(5):458-465.
  • Nanni, Gregg s_ et al, Control of Hypertension by Ethanol Renal Ablation, Radiology 148: 51-54, Jul. 1983.
  • Ndegwa, S., Catheter-Based Renal Denervation for Treatment-Resistant Hypertension [Issues in emerging health technologies issue 121]. Ottawa: Canadian Agency for Drugs and Technologies in Health; Mar. 2013.
  • Neutel, Joel M., Hypertension and Its Management: A Problem in Need of New Treatment Strategies, Journal of Renin-Angiotensin-Aldosterone System 2000 1: S10-S13.
  • Newcombe, C.P. et al, Sympathectomy for Hypertension, British Medical Journal, Jan. 1959, 142-144.
  • Ng, Fu Siong et al, Catheter Ablation of Atrial Fibrillation, Clinical Cardiology, 25, 384-394 (2002).
  • Norman, Roger A. et al, Role of the Renal Nerves in One-Kidney, One Clip Hypertension in Rats, Hypertension Journal of the American Heart Association, 1984;6:622-626.
  • Nozawa, Takashi et al, Effects of Long-Term Renal Sympathetic Denervation on Heart Failure After Myocardial Infarction in Rats, Heart Vessels (2002) 16:51-56.
  • O'Connor, Brian K. et al, Radiofrequency Ablation of a Posteroseptal Accessory Pathway via the Middle Cardiac vein in a Six-Year-Old Child, PACE, vol. 20, Oct. 1997, Part 1, 2504-2507.
  • O'Hagen, Kathleen P. et al, Renal Denervation Decreases Blood Pressure in DOCA-Treated Miniature Swine With Established Hypertension, American Journal of Hypertension, 1990; 3:62-64.
  • Oliveira, Vera LL. et al, Renal Denervation Normalizes Pressure and Baroreceptor Reflex in High Renin Hypertension in Conscious Rats, Hypertension vol. 19, No. 2 Feb. 1992, Supplement 11, 11-17-11-21.
  • Omran, Heyder et al, Echocardiographic Imaging of Coronary Sinus Diverticula and Middle Cardiac Veins in Patients with Preexcitation Syndrome: Impact—on Radiofrequency Catheter Ablation of Posteroseptal Accessory Pathways, PACE, vol. 18, Jun. 1995, 1236-1243.
  • Oparil, Suzanne et al, Renal Nerve Ablation: Emerging Role in Therapeutics; Blood Pressure, Oct. 2011, vol. 20, No. 5 , pp. 253-255.
  • Oral, Hakan et al, Pulmonary Vein Isolation for Paroxysmal and Persistent Atrial Fibrillation, Circulation Journal of the American Heart Association, 2002;105:1077-1081.
  • Osborn, Jeffrey L. et al, Long-Term Increases in Renal Sympathetic Nerve Activity and Hypertension, Clinical and Experimental Pharmacology and Physiology (1997) 24,72-76.
  • Osborn, John W., The Sympathetic Nervous System and Long-Term Regulation of Arterial Pressure: What Are the Critical Questions?, Clinical and Experimental Pharmacology and Physiology (1997) 24, 68-71.
  • Ou, Baiqing et al, Baroreflex Sensitivity Predicts the Induction of Ventricular Arrhythmias by Cesium Chloride in Rabbits, Japanese Circulation Journal, 1999; 63: 783-788.
  • Oz, Mehmet, Pressure Relief, Time Magazine, Monday, Jan. 9, 2012.
  • Page, Irvine H. et al, Mechanisms, Diagnosis and Treatment of Hypertension of Renal Vascular Origin, Annal of Internal Medicine, Aug. 1959, vol. 51, No. 2, 196-211.
  • Page, Irvine H. et al, Mechanisms, Diagnosis and Treatment of Hypertension of Renal Vascular Origin; Annals of Internal Medicine, Aug. 1959;51:196-211.
  • Page, Irvine H. et al, The Effect of Renal Denervation on the Level of Arterial Blood Pressure and Renal Function in Essential Hypertension, Journal of Clinical Investigation, 1935;14(1):27-30.
  • Page, Irvine H. et al, The Effects of Renal Denervation on Patients Suffering from Nephritis, J Clin Invest. 1935;14(4):443-458.
  • Page, Irvine H., The Effect of Renal Efficiency of Lowering Arterial Blood Pressure in Cases of Essential Hypertension and Nephritis, Journal of Clinical Investigation, Nov. 1934; 13(6): 909-915.
  • Page, Max, Section of Surgery, Discussion on the Surgical Treatment of Hypertension, Proceedings of the Royal Society of Medicine, vol. XLI, Feb. 1948, 359-372.
  • Papademetriou, Vasilios, Hypertension and the Simplicity Renal Denervation System, Scientific Background, www.medtronic.com, 2011.
  • Pappone, Carlo et al, Circumferential Radiofrequency Ablation of Pulmonary Vein Ostia: A New Anatomic Approach for Curing Atrial Fibrillation, Circulation, Journal of The American Heart Association, 2000;102:2619-2628.
  • Parati, Gianfranco et al, The Human Sympathetic Nervous System: Its Relevance in Hypertension and Heart Failure, European Heart Journal (2012) 33, 1058-1066.
  • Parmar, Arundhati, Analyst: Medtronic Will Likely Acquire Another Hypertension Therapy Firm, Medcity News, Apr. 27, 2012; 3:06 p.m.; medcitynews.com.
  • Pavlovich, Christian P. et al, Percutaneous Radio Requency Ablation of Small Renal Tumors: Initial Results; The Journal of Urology, vol. 167, Jan. 10-15, 2002.
  • Pearce, John A_ et al, Blood Vessel Architectural Features and Their Effect on Thermal Phenomena, Critical Reviews, vol. CR75,, Bellingham, WA: SPIE Optical Engineering Press; 2000, p. 231-277.
  • Peet, Max Minor, Hypertension and Its Surgical Treatment by Bilateral Supradiaphragmatic Splanchnicectomy, American Journal of Surgery, vol. 75, Issue 1, Jan. 1948, 48-68.
  • Perry, C. Bruce, Malignant Hypertension Cured by Unilateral Nephrectomy, British Heart Journal, Jul. 1945; 7(3):139-142.
  • Persu, Alexandre et al, Renal Denervation: Ultima Ratio or Standard in Treatment-Resistant Hypertension, Hypertension Journal of The American Heart Association, Sep. 2012;60(3):596-606.
  • Peterson, Helen Hogh et al, Lesion Dimensions During Temperature-Controlled Radiofrequency Catheter Ablation of Left Ventricular Porcine Myocardium Impact of Ablation Site, Electrode Size, and Convective Cooling, Circulation Journal of The American Heart Association, 1999;99:319-325.
  • Plouin, Pierre-Francois et al, Blood Pressure Outcome of Angioplasty in Atherosclerotic Renal Artery Stenosis A Randomized Trial, Hypertension Journal of The American Heart Association, 1998;31:823-829.
  • Poutasse, Eugene F., Surgical Treatment of Renal Hypertension, American Journal of Surgery, vol. 107, Jan. 1964, 97-103.
  • Pugsley, MK et al, The Vascular System An Overview of Structure and Function, Journal of Pharmacological and Toxicological Methods 44 (2000) 333-340.
  • Putney, John Paul, Are Secondary Considerations Still “Secondary”?:An Examination of Objective Indicia of Nonobviousness Five Years AHer KSR, Intellectual Property Brief, vol. 4, Issue 2, Article 5, 2012, 45-59.
  • Ramsay, Lawrence E. et al, Blood Pressure Response to Percutaneous Transluminal Angioplasty for Renovascular Hypertension: An Overview of Published Series; British Medical Journal Mar. 3, 1990; 300(6724): 569-572.
  • Rippy, Marian K. et al, Catheter-Based Renal Sympathetic Denervation: Chronic Preclinical Evidence for Renal Artery Safety, Clin Res Cardiol (2011) 100:1095-1101.
  • Ritz, Eberhard, New Approaches to Pathogenesis and Management of Hypertension, Clin J Am Soc Nephrol 4:1886-1B91,2009.
  • Santos, Mario et al, Renal Sympathetic Denervation in Resistant Hypertension, World J Cardiol Apr. 26, 2013; 5(4)94-101.
  • Schlaich, Markus P. et al, International Expert Consensus Statement: Percutaneous Transluminal Renal Denervation for the Treatment of Resistant Hypertension, Journal of the American College of Cardiology vol. 62, Issue 22, Dec. 3, 2013, pp. 2031-2045.
  • Stuart, Candace, Newest Frontier in Cardiac Care: Kidneys; Cardiovascular Business, Dec. 13, 2012.
  • Stuart, Mary, Masterminds of Ardian: An Interview With Inventors Mark Gelfand and Howard Levin, Windhover Information, Start-Up Jan. 1, 2011.
  • Thiebot, J. et al, Bilateral Nephrectomy by Embolization of the Renal Arteries: A Report on Five Cases (author's transl), Sem Hop. Apr. 8-15, 1980;56(13-14):670-5.
  • Worthley, Stephen G. et al, Renal Denervation: How Do You Measure Success?, presentation 28 pages; Jul. 30, 2013.
  • Abboud, Francois M., The Sympathetic System in Hypertension, Slate-of-the-Art Review, Hypertension Journal of The American Heart Association, Hypertension 4 (suppl II): 11-208-11-225, 1982.
  • Allen, Edgar V., Sympathectomy for Essential Hypertension, Circulation Journal of the American Heart Association, vol. VI, Jul. 1952, 131-140.
  • Anderson, Erling A. et al, Elevated Sympathetic Nerve Activity in Borderline Hypertensive Humans, Evidence From Direct Intraneural Recordings, Hypertension Journal of the American Heart Association, vol. 14, No. 2, Aug. 1989, 177-183.
  • Ardian, Inc., Ardian(R) Receives 2010 EuroPCR Innovation Award and Demonstrates Further Durability of Renal Denervation Treatment for Hypertension, PR Newswire, Jun. 3, 2010.
  • Arentz, Thomas et al, Feasibility and Safety of Pulmonary Vein Isolation Using a New Mapping and Navigation System in Patients with Refractory Atrial Fibrillation, Circulation Journal of the American Heart Association, Nov. 18, 2003, 2484-2490.
  • Badoer, Emilio et al, Cardiac Afferents Play the Dominant Role in Renal Nerve Inhibition Elicited by Volume Expansion in the Rabbit, American Journal of Physiology, 1998, R383-R388.
  • Bakris, George L. et al, Baroreflex Activation Therapy Provides Durable Benefit in Patients with Resistant Hypertension: Results of Long-Term Follow-up in the Rheas Pivotal Trial, J Am Soc Hypertens. Mar.-Apr. 2012;6(2):152-8.
  • Bao, Gang et al, Blood Pressure Response to Chronic Episodic Hypoxia: Role of the Sympathetic Nervous System, American Journal of Physiology, 1997, 95-101.
  • Barajas, Luciano et al, Anatomy of the Renal Innervation: Intrarenal Aspects and Ganglia of Origin, Canadian Journal of Physiology and Pharmacology, vol. 70, No. 5, May 1992, 735-749.
  • Barajas, Luciano et al, Monoaminergic Innervation of the Rat Kidney: A Quantitative Study, American Journal of Physiology, vol. 259, No. 3, Sep. 1990, F503-F511.
  • Bardram, Linda et al, Late Results After Surgical Treatment of Renovascular Hypertension, A Follow-up Study of 122 Patients 2-18 Years After Surgery, Annals of Surgery, vol. 201, No. 2, Feb. 1985, 219-224.
  • Bello-Reuss, Elsa et al, Effect of Renal Sympathetic Nerve Stimulation on Proximal Water and Sodium Reabsorption, The Journal of Clinical Investigation, vol. 57, Apr. 1976, 1104-1107.
  • Bello-Reuss, Elsa et al, Effects of Acute Unilateral Renal Denervation in the Rat, The Journal of Clinical Investigation, vol. 56, Jul. 1975, 208-217.
  • Benito, Fernando et al, Radiofrequency Catheter Ablation of Accessory Pathways in Infants, Heart, 1997, 78, 160-162.
  • Bernardi, Luciano et al, Influence of Type of Surgery on the Occurrence of Parasympathetic Reinnervation After Cardiac Transplantation, Circulation Journal of the American Heart Association, Apr. 14, 1998;97(14):1368-74.
  • Bertog, Stefan C. et al, Renal Denervation for Hypertension, JACC: Cardiovascular Interventions, vol. 5, No. 3, Mar. 2012, 249-258.
  • Bertram, Harald et al, Coronary Artery Stenosis After Radiofrequency Catheter Ablation of Accessory Atrioventricular Pathways in Children with Ebstein's Malformation, Circulation Journal of the American Heart Association, 2001, 538-543.
  • Blankestijn, Peter J. et al, Renal Denervation: Potential Impact on Hypertension in Kidney Disease?, Nephrol Dial Transplant (2011) O: 1-3.
  • Blankestijn, Peter J. et al, Sympathetic Overactivity in Renal Failure Controlled by ACE Inhibition: Clinical Significance, Nephrol Dial Transplant, 2000, 15, 755-758.
  • Blum, Ulrich et al, Treatment of Ostial Renal-Artery Stenoses with Vascular Endoprostheses After Unsuccessful Balloon Angioplasty, The New England Journal of Medicine, vol. 336, No. 7, Feb. 1997, 459-465.
  • Brinkmann, Julia et al, Catheter-Based Renal Nerve Ablation and Centrally Generated Sympathetic Activity in Difficult-to-Control Hypertensive Patients Prospective Case Series, Hypertension. 2012;60:1485-1490.
  • Brookes, Linda et al, Renal Denervation: Is Reality Meeting Expectations?, An Interview with Michel Azizi, MD, PhD, Medscape, Jan. 7, 2013.
  • Bunte, Matthew C. et al, Endovascular Treatment of Resistant and Uncontrolled Hypertension, JACC: Cardiovascular Interventions, vol. 6, No. 1, Jan. 2013, 1-9.
  • Calleary, Hickey D. et al, Pre-Transplant Bilateral Native Nephrectomy for Medically Refractory Hypertension, The Irish Medical Journal, Jul.-Aug. 2001;94(7):214-6.
  • Callens, David J. et al, Narrowing of the Superior Vena Cava-Right Atrium Junction During Radiofrequency Catheter Ablation for Inappropriate Sinus Tachycardia: Analysis with Intracardiac Echocardiography, Journal of the American College of Cardiology, vol. 33, No. 6, 1999, 1667-1670.
  • Campese, V.M., Is Hypertension in Chronic Renal Failure Neurogenic in Nature?, Nephrol Dial Transplant, 1994, 9: 741-742.
  • Campese, Vito M. et al, Neurogenic Factors in Renal Hypertension, Current Hypertension Reports, 2002 4: 256-260.
  • Campese, Vito M_ et al, Renal Afferent Denervation Prevents Hypertension in Rats With Chronic Renal Failure, Hypertension, 1995, 25, 878-882.
  • Campese, Vito M_ et al, Renal Afferent Denervation Prevents the Progression of Renal Disease in the Renal Ablation Model of Chronic Renal Failure in Rat, American Journal of Kidney Disease, vol. 26, No. 5, Nov. 1995, 861-865.
  • Campese, Vito M., Interventional Hypertension: A New Hope or a New Hype? The Need to Redefine Resistant Hypertension, J Hypertens. Nov. 2013; 31 (11 ):2118-21.
  • Canadian Agency for Drugs and Technologies in Heal TH, Catheter-Based Renal Denervation for Wreatment-Resistant Hypertension; Issues in Emerging Health Technologies, Issue 121, Mar. 2013.
  • Carlstedt, Thomas et al, Regrowth of Lesioned Dorsal Root Nerve Fibers into the Spinal Cord of Neonatal Rats, Neuroscience Letters Feb. 10, 1987;74(1):14-8.
  • Chabanier, H_ et al, On the Decapsulation and Neurectomy of the Kidnesy in Permanent Hypertensive States, The Medical Press, Feb. 22, 1936, No. 16, 307-310.
  • Ciccone, C D et al, Effects of Acute Renal Denervation on Kidney Function in Deoxycorticosterone Acetate-Hypertensive Swine, Hypertension Journal of the American Heart Association, Oct. 1986, vol. 8, No. 10, 925-931.
  • Ciriello, John et al, Renal Afferents and Hypertension, Current Hypertension Reports 2002, 4:136-142.
  • Converse, Richard L. et al, Sympathetic Overactivity in Patients with Chronic Renal Failure, The New England Journal of Medicine, vol. 327, No. 27, 1992, 1912-1918.
  • Crile, George, The Clinical Results of Celiac Ganglionectomy in the Treatment of Essential Hypertension, Annals of Surgery, Jun. 1938; 107(6): 909-916.
  • Cruickshank, J.M., Beta-Blockers Continue to Surprise Us, European Heart Journal (2000) 21, 354-364.
  • Curtis, John J_ et al, Surgical Therapy for Persistent Hypertension After Renal Transplantation, Transplantation, vol. 31, No. 2, 1981, 125-128.
  • Dailey, U.G., Surgical Treatment of Hypertension: A Review—Part 11, Journal of the National Medical Association, May 1948, vol. 40, No. 3., 113-116.
  • Dailey, U.G., Surgical Treatment of Hypertension: A Review—Part 111, Journal of the National Medical Association, Jul. 1948, vol. 40, No. 4, 160-162.
  • Dailey, U.G., The Surgical Treatment Of Hypertension: A Review, Journal of the National Medical Association, Mar. 1948, vol. 40, No. 2, 76-79.
  • Davis, Mark I. et al, Effectiveness of Renal Denervation Therapy for Resistant Hypertension A Systematic Review and Meta-Analysis, Journal of the American College of Cardiology, vol. 62, No. 3, Jul. 16, 2013, 231-241.
  • De Wardener, H.E., The Hypothalamus and Hypertension, Physiological Reviews,vol. 81, No. 4, Oct. 2001.
  • Dequattro V_ et al, The Sympathetic Nervous System: The Muse of Primary Hypertension, Journal of Human Hypertension, 2002, 16 (Suppl 1 ), S64-S69.
  • Dibona, Gerald F. et al, Neural Control of Renal Function, Physiological Reviews, vol. 77, No. 1, Jan. 1997, 175-197.
  • Dibona, Gerald F. et al, Translational Medicine: The Antihypertensive Effect of Renal Denervation, America! Journal of Physiology, 2010, 298, R245-R253.
  • Dibona, Gerald F., Neural Control of Renal Function: Cardiovascular Implications, Hypertension Journal of The American Heart Association, vol. 13, No. 6, Part 1, Jun. 1989, 539-548.
  • Dibona, Gerald F., Neural Control of the Kidney: Functionally Specific Renal Sympathetic Nerve Fibers, American Journal of Physiology, 2000, 279, R1517-R1524.
  • Dibona, Gerald F., Neural Control of the Kidney: Past, Present, and Future, Hypertension Journal of The American Heart Association, vol. 41, Mar. 2003, Part 11, 621-624.
  • Jaff, Michael R. et al, Kidney Stenting Lowers Blood Pressure in Patients with Severe Hypertension; Catheterization and Cardiovascular Interventions; Published Online: Jun. 27, 2012 (DOI: 10.1002/ccd.24449); Print Issue Date: Sep. 2012. URL: http://onlinelibrary .wiley _com/doi/10 .1002/ccd .24449/abstract.
  • Jin, Yu et al, No Support for Renal Denervation in a Meta-Analysis, JACC vol. 62, No. 21, 2013 Correspondence Nov. 19-26, 2013:2029--30.
  • Kaltenbach, Benjamin et al, Renal Artery Stenosis After Renal Sympathetic Denervation, J Am Coll Cardiol. Dec. 25, 2012;60(25):2694-5.
  • Krum, Henry et al, Catheter-Based Renal Sympathetic Denervation for Resistant Hypertension: A Multicentre Safety and Proof-of-Principle Cohort Study, www.thelancet.com vol. 373 Apr. 11, 2009 1275-1281.
  • Luscher, Thomas F. et al, Renal Nerve Ablation After Symplicity HTN-3: Confused at the Higher Level?; European Heart Journal, doi:10.1093/eurheartj/ehu195; May 14, 2014.
  • Mahfoud, Felix et al, Expert Consensus Document from the European Society of Cardiology on Catheter-Based Renal Denervation, European Heart Journal, Apr. 25, 2013; 34(28):2149-57.
  • Medtronic, Inc., J.P. Morgan Healthcare Conference, Corrected Transcript, Jan. 13, 2014, Factset:Callstreet, www.callstreet.com.
  • Medtronic, Inc., Medtronic Announces U.S. Renal Denervation Pivotal Trial Fails to Meet Primary Efficacy Endpoint While Meeting Primary Safety Endpoint, www.medtronic.com, Jan. 9, 2014.
  • Millard, F.C. et al, Renal Embolization for Ablation of Function in Renal Failure and Hypertension, Postgraduate Medical Journal (1989) 65, 729-734.
Patent History
Patent number: D914883
Type: Grant
Filed: Dec 20, 2017
Date of Patent: Mar 30, 2021
Assignee: ST. JUDE MEDICAL, CARDIOLOGY DIVISION, INC. (St. Paul, MN)
Inventors: Sara A. Thompson (Maple Grove, MN), Mark A. Catron (Superior, CO), Eric Collins (Superior, CO), Matija Klemenc (Louisville, CO), Karen M. Kensok (Minnetonka, MN), John B. Blix (Maple Grove, MN)
Primary Examiner: Rhea Shields
Application Number: 29/630,310
Classifications
Current U.S. Class: Electrosurgical (42) (D24/170)